fda approval status of cjc 1295 and ipamorelin CJC-1295 / | Clinician-Reviewed Peptide Therapy CJC-1295 Ipamorelin Blend Peptide |
Description
Thank you so much Melissa for your custom cocktail

Community reports suggest approximately 60% better outcomes with the combination compared to either peptide individually
Acknowledgments Schematic illustrations are created with BioRender.com and Scidraw.io

These unknowns do not invalidate the existing safety data
